klhl15 Antibody

What is KLHL15 and why is it important to study using antibody-based approaches?

KLHL15 is a member of the kelch-like family of proteins that functions as a substrate adaptor for CUL3-containing E3 ubiquitin ligase complexes. It contains an N-terminal broad-complex, tramtrack, bric-a-brac/poxvirus and zinc finger domain and C-terminal kelch repeat motifs, which are essential for its function . The protein plays critical roles in multiple cellular processes, most notably in DNA double-strand break repair pathway choice and neuronal development .

Antibody-based approaches are essential for studying KLHL15 because they allow researchers to:

• Detect endogenous KLHL15 expression levels in different cell types and tissues

• Observe subcellular localization through immunocytochemistry

• Identify protein-protein interactions via co-immunoprecipitation

• Monitor changes in KLHL15 levels in response to various stimuli

• Validate genetic knockdown or knockout studies

Mutations in the KLHL15 gene have been associated with X-linked intellectual disability, highlighting its importance in brain development and function . The protein mediates the degradation of critical substrates including CtIP (involved in DNA repair), PP2A/B'β subunit, and doublecortin (DCX) and its related kinases DCLK1/2 .

How should I select the appropriate KLHL15 antibody for my experiment?

Selecting the appropriate KLHL15 antibody requires careful consideration of several factors:

For Western blot applications, antibodies targeting the C-terminal region can be particularly effective as demonstrated in knockdown validation studies . For co-immunoprecipitation experiments when studying KLHL15 binding partners, consider antibodies that don't interfere with protein-protein interaction domains .

Before proceeding with experiments, validate the antibody specificity using positive controls (HeLa or HEK293 cell lysates) and negative controls (KLHL15 knockout or knockdown samples) to ensure reliable results .

What are the optimal conditions for Western blot detection of KLHL15?

For optimal Western blot detection of KLHL15, follow these methodological guidelines:

• Sample preparation:

  • Lyse cells in buffer containing protease inhibitors to prevent degradation

  • Include phosphatase inhibitors if studying phosphorylation-dependent interactions

  • Heat samples at 95°C for 5 minutes in Laemmli buffer with reducing agent

• Gel electrophoresis:

  • Use 8-10% SDS-PAGE gels for optimal separation around the expected molecular weight of 69-70 kDa

  • Load appropriate positive controls (HeLa or HEK293 cell lysates)

• Transfer and blocking:

  • Transfer to PVDF membrane at 100V for 90 minutes in 10% methanol transfer buffer

  • Block with 5% non-fat milk in TBST for 1 hour at room temperature

• Antibody incubation:

  • Primary antibody dilution: 1:500-1:2,000 in blocking buffer

  • Incubate overnight at 4°C with gentle rocking

  • Secondary antibody: Anti-rabbit HRP at 1:5,000-1:10,000 for 1 hour at room temperature

• Detection:

  • Enhanced chemiluminescence (ECL) reagents work well for visualizing KLHL15

  • Expected band size: 69-70 kDa

Troubleshooting tip: If detecting multiple bands, perform validation experiments with KLHL15 siRNA/shRNA knockdown or CRISPR/Cas9 knockout samples to confirm specificity, as demonstrated in previous studies where KLHL15 deletion correlated with increased levels of its substrates like CtIP .

How can I validate KLHL15 antibody specificity for immunofluorescence studies?

Validating KLHL15 antibody specificity for immunofluorescence requires a multi-faceted approach:

• Gene silencing controls:

  • Implement CRISPR/Cas9 knockout of KLHL15 as done by Munoz et al., which demonstrated perfect correlation between KLHL15 absence and increase in substrate proteins

  • Alternatively, use siRNA or shRNA-mediated knockdown of KLHL15

• Peptide competition assay:

  • Pre-incubate the primary antibody with the immunizing peptide (e.g., PEP-0885 for antibody PA5-20771)

  • A significant reduction in signal indicates specificity toward the target epitope

• Orthogonal antibody validation:

  • Compare staining patterns using antibodies targeting different KLHL15 epitopes

  • Use antibodies raised in different host species or with different clonality

• Subcellular localization correlation:

  • Perform co-localization studies with established markers of cellular compartments where KLHL15 is expected to function (e.g., proteasome markers)

  • Express tagged KLHL15 (GFP-KLHL15) and compare localization with antibody staining

• Standardized protocol for immunofluorescence:

  • Fix cells in 4% paraformaldehyde for 15 minutes at room temperature

  • Permeabilize with 0.2% Triton X-100 for 10 minutes

  • Block with 3% BSA in PBS for 1 hour

  • Incubate with KLHL15 antibody at 5 μg/mL overnight at 4°C

  • Use appropriate fluorophore-conjugated secondary antibodies

  • Include DAPI counterstain for nuclear visualization

The specificity of KLHL15 antibodies has been demonstrated in previous studies through these validation methods, confirming authentic cellular localization patterns .

What approach should I use to study KLHL15-substrate interactions in cellular models?

Studying KLHL15-substrate interactions requires sophisticated methodological approaches:

• Co-immunoprecipitation (Co-IP):

  • Perform reciprocal IP experiments (both KLHL15 IP and substrate IP)

  • Example protocol from published research :

    • Transfect cells with GFP-tagged KLHL15 and FLAG-tagged substrate

    • Lyse cells in buffer containing 50 mM HEPES pH 7.4, 150 mM NaCl, 1% Triton X-100

    • Immunoprecipitate with anti-GFP or anti-FLAG antibodies

    • Analyze by Western blot to detect protein interactions

• GST pull-down assays:

  • Generate GST-KLHL15 Kelch domain fusion proteins (amino acids 255-604)

  • Incubate with cell/tissue lysates (e.g., E18 rat embryo brain lysates)

  • Successful at capturing endogenous substrates including PP2A/B'β, DCX, DCLK1, and DCLK2

  • Include GST alone and unrelated GST-fusion proteins (e.g., GST-KLHL9 Kelch) as negative controls

• Ubiquitination assays:

  • Co-transfect HA-tagged ubiquitin, GFP-tagged KLHL15, and FLAG-tagged substrate

  • Treat cells with proteasome inhibitor MG132 (10 μM for 4-6 hours)

  • Perform FLAG-IP and probe for polyubiquitinated species using substrate-specific antibodies

  • Compare wild-type substrate with mutants lacking critical KLHL15 interaction motifs (e.g., FRY tripeptide)

• Protein half-life determination:

  • Use HaloTag-based pulse-chase protocols for long-lived proteins

  • Alternative approach: cycloheximide chase assays

  • Compare protein degradation rates in cells overexpressing KLHL15 versus KLHL15 knockdown

• Substrate interaction motif mapping:

  • Point mutations within the FRY sequence of substrates (e.g., DCX-Y259L, DCLK1-Y265L, DCLK2-Y276L) disrupt interactions with KLHL15

  • Generate deletion constructs to map minimal binding regions

  • Perform quantitative binding assays using purified components

Research has shown that KLHL15 substrate recognition often depends on a conserved FRY tripeptide motif, which is critical for binding to the Kelch domain of KLHL15 .

How can I assess KLHL15 function in DNA repair pathways using antibody-based methods?

Assessing KLHL15 function in DNA repair pathways requires sophisticated experimental approaches:

• DNA damage response monitoring:

  • Treat cells with DNA damaging agents (e.g., camptothecin, ionizing radiation)

  • Perform immunofluorescence for KLHL15 and DNA damage markers (γ-H2AX, 53BP1)

  • Analyze co-localization and temporal dynamics of KLHL15 recruitment to damage sites

• KLHL15 manipulation and phenotypic assessment:

  • Overexpress wild-type KLHL15 or substrate-binding mutants (e.g., KLHL15-Y552A)

  • Create KLHL15 knockdown/knockout cell lines

  • Quantitative phenotypic assays:

    • Single-strand DNA (ssDNA) formation: BrdU incorporation and staining under non-denaturing conditions

    • Homologous recombination (HR) reporter assays: significant reduction in HR frequency observed with wild-type KLHL15 overexpression but not with Y552A mutant

    • Proxy measures of DNA-end resection like RPA or CtIP foci formation

• Biochemical assessment of substrate levels:

  • Analyze CtIP protein levels by Western blot following KLHL15 overexpression or depletion

  • Study correlation between KLHL15 expression and DNA repair protein stability

  • Research has demonstrated that KLHL15 overexpression reduces CtIP levels and attenuates DNA-end resection, while KLHL15 knockout enhances resection

• Functional DNA repair assays:

  • Comet assay to measure DNA breaks

  • Cell survival assays following DNA damage

  • Sister chromatid exchange frequency assessment

Published research indicates that KLHL15 regulates the balance between homologous recombination and non-homologous end joining by controlling the protein levels of key factors like CtIP through the ubiquitin-proteasome system .

What might cause inconsistent KLHL15 detection in Western blots?

Several factors may contribute to inconsistent KLHL15 detection in Western blots:

KLHL15 is detected at approximately 69-70 kDa, but variations may occur due to post-translational modifications . Research shows that KLHL15 protein levels may fluctuate in response to cellular conditions, particularly during DNA damage responses .

How do I interpret changes in KLHL15 levels in different experimental conditions?

Interpreting changes in KLHL15 levels requires careful analysis within the context of experimental conditions:

• Cell cycle regulation:

  • Assess cell cycle distribution in your samples

  • Normalize KLHL15 levels to appropriate housekeeping proteins

  • Consider cell synchronization for comparing equivalent populations

• DNA damage response:

  • Document KLHL15 dynamics following treatment with DNA damaging agents

  • Compare to known DNA damage response proteins

  • Research indicates KLHL15 plays a critical role in regulating DNA repair pathway choice through controlling substrate protein levels

• Tissue-specific expression:

  • KLHL15 mRNA is widely expressed in many tissues

  • Compare protein expression with documented tissue-specific patterns

  • Consider physiological relevance of expression levels

• Quantification approaches:

  • Use appropriate loading controls (β-actin, GAPDH)

  • Perform densitometry analysis from multiple independent experiments

  • Present data as fold-change relative to control conditions

• Substrate correlation analysis:

  • Analyze inverse correlation between KLHL15 and its substrates

  • Research demonstrates perfect positive correlation between KLHL15 absence and increase of CtIP protein levels

  • Similar inverse relationships observed with other substrates like DCX, DCLK1, and DCLK2

When interpreting results, consider that KLHL15 functions as part of Cullin3-based E3 ubiquitin ligase complexes, and changes in its levels can significantly impact substrate protein stability and associated cellular processes .

What controls should I include when studying KLHL15-mediated protein degradation?

When studying KLHL15-mediated protein degradation, include the following essential controls:

• Substrate specificity controls:

  • Known KLHL15 substrates as positive controls (CtIP, PP2A/B'β, DCX, DCLK1/2)

  • Non-substrate proteins as negative controls (e.g., DCLK3, RIβ)

  • Substrate mutants lacking KLHL15 interaction motifs (e.g., Y to L substitutions in FRY sequences)

• KLHL15 functionality controls:

  • Wild-type KLHL15 vs. substrate-binding deficient mutant (KLHL15-Y552A)

  • KLHL15 knockdown/knockout cells created by siRNA/shRNA or CRISPR/Cas9

  • Related Kelch-like proteins (e.g., KLHL9) to demonstrate specificity

• Ubiquitin-proteasome system controls:

  • Proteasome inhibitors (MG132, 10 μM for 4-6 hours)

  • Ubiquitin mutants (lysine-48 vs. lysine-63 linkage-specific)

  • Cullin3 knockdown or dominant-negative constructs

• Protein stability measurement controls:

  • Cycloheximide chase with different time points (0, 2, 4, 8, 24 hours)

  • HaloTag pulse-chase for long-lived proteins

  • Different cell types to assess tissue-specific degradation patterns

• Experimental condition controls:

  • Expression level verification (input samples before immunoprecipitation)

  • Loading controls for Western blots

  • Transfection efficiency normalization

Research has demonstrated that overexpression of wild-type KLHL15, but not substrate-binding deficient mutants, dramatically decreases steady-state levels of target proteins through ubiquitination and proteasomal degradation .

How can KLHL15 antibodies be used to investigate neurodevelopmental disorders?

KLHL15 antibodies can be instrumental in investigating neurodevelopmental disorders through several methodological approaches:

• Clinical sample analysis:

  • Compare KLHL15 expression in post-mortem brain tissues from patients with neurodevelopmental disorders versus controls

  • Employ immunohistochemistry with KLHL15 antibodies on brain tissue sections (1:50-1:500 dilution)

  • Analyze KLHL15 substrate levels (DCX, DCLK1/2) in patient-derived samples

• Neural cell culture models:

  • Study KLHL15 expression during neuronal differentiation

  • Assess dendritic morphology in neurons with altered KLHL15 expression

  • Research has shown that KLHL15 overexpression reduces dendritic complexity in cultured hippocampal neurons when wild-type DCX is present

• KLHL15 mutation analysis:

  • Generate cell models with patient-specific KLHL15 mutations

  • KLHL15 mutations are associated with various brain abnormalities and developmental disorders in male patients

  • Compare substrate degradation efficiency between wild-type and mutant KLHL15

• Neuronal signaling pathways:

  • Investigate KLHL15's effect on neurotrophin signaling

  • Studies show that KLHL15 influences ERK signaling by regulating PP2A/B'β levels, which affects BDNF-mediated Elk1 transcriptional activity in neurons

• Brain development studies:

  • Track KLHL15 expression during embryonic brain development

  • Correlate with expression of substrates involved in neuronal migration and differentiation

  • KLHL15 mediates ubiquitination and degradation of DCX and DCLKs, which are critical for proper brain development

The X-linked intellectual disability phenotype associated with KLHL15 mutations underscores the importance of this protein in proper brain development and function, making KLHL15 antibodies valuable tools for investigating neurological disorders .

What are the best approaches for studying KLHL15 interactions with the ubiquitin-proteasome system?

To effectively study KLHL15 interactions with the ubiquitin-proteasome system (UPS):

• In vivo ubiquitination assays:

  • Co-transfect cells with HA-tagged ubiquitin, GFP-tagged KLHL15, and FLAG-tagged substrate

  • Treat with proteasome inhibitor MG132 (10 μM, 4-6 hours)

  • Immunoprecipitate substrate and probe for polyubiquitin chains

  • Research shows KLHL15 overexpression promotes robust ubiquitination of substrates dependent on the FRY motif

• Reconstituted in vitro ubiquitination system:

  • Purify components (E1, E2, Cul3-Rbx1, KLHL15, substrate)

  • Assemble reactions with ATP and ubiquitin

  • Analyze by Western blot for substrate modification

  • Include controls lacking individual components

• Proteasome association studies:

  • Immunoprecipitate KLHL15 and probe for proteasome subunits

  • Perform proximity ligation assays to visualize KLHL15-proteasome interactions

  • Use proteasome inhibitors to trap transient interactions

• Cullin3 and Rbx1 co-factor analysis:

  • KLHL15 functions as a substrate adaptor for Cullin3-containing E3 ubiquitin ligases

  • Co-immunoprecipitation of KLHL15 with Cullin3 and Rbx1

  • Domain mapping to identify critical interaction regions

• Quantitative proteomic approaches:

  • SILAC-based quantification of ubiquitinated proteome after KLHL15 manipulation

  • IP-mass spectrometry to identify novel KLHL15-associated proteins

  • Compare proteomes of KLHL15 wild-type versus knockout cells

KLHL15 contains BTB/POZ domains that mediate interaction with Cullin3 and Kelch domains that recognize substrates, making it a critical component of CUL3-based E3 ubiquitin ligase complexes . These experimental approaches can uncover the mechanisms by which KLHL15 selectively targets proteins for degradation.

How can I investigate the role of KLHL15 in regulating cell-type specific proteostasis?

To investigate KLHL15's role in cell-type specific proteostasis:

• Tissue and cell-type expression profiling:

  • Perform immunohistochemistry across multiple tissues

  • Validated for human prostate cancer tissue, human testis tissue, and human brain tissue

  • Compare KLHL15 levels in different cell types using Western blot and immunofluorescence

• Cell-type specific knockout models:

  • Generate conditional KLHL15 knockout models (e.g., Cre-loxP system)

  • Target specific cell types (neurons, glia, stem cells)

  • Analyze proteome changes in knockout versus wild-type cells

• Substrate repertoire analysis:

  • Compare KLHL15 substrates across different cell types

  • Known substrates include CtIP, PP2A/B'β, DCX, DCLK1/2

  • Immunoprecipitate KLHL15 from different tissues/cell types and identify associated proteins by mass spectrometry

• Stress response studies:

  • Challenge cells with various stressors (oxidative, proteotoxic, genotoxic)

  • Monitor KLHL15-dependent protein degradation during stress responses

  • Compare stress tolerance in cells with normal versus altered KLHL15 expression

• Developmental timing analysis:

  • Track KLHL15 expression during development

  • Correlate with proteome changes at critical developmental timepoints

  • Focus on neurodevelopmental processes given KLHL15's role in X-linked intellectual disability

Experimental evidence suggests cell-type specific functions of KLHL15, particularly in neurons where it regulates DCX and DCLK proteins to influence neuronal morphology and development . Additionally, KLHL15's role in DNA repair through CtIP regulation suggests tissue-specific importance in proliferating versus post-mitotic cells .

This comprehensive approach will elucidate how KLHL15 contributes to proteostasis networks in different cellular contexts, potentially revealing therapeutic targets for conditions with dysregulated protein turnover.